HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Church & Dwight ‘Left Money On Table’ In Q1, Same Supply Chain Problems Expected Q2 Before Easing

Executive Summary

“We have the orders, we’re just struggling to fill them either due to production problems or transportation issues,” says CEO Matthew Farrell.

You may also be interested in...



HBW Product Launches: Preminity, Dr. Formulated, Clear Focus, Zicam Immune, Synergy Plus

Garden of Life offers Triple Action Dr. Formulated; BasicBites Synergy Plus for oral care; Zicam extends to Daily Immune Support and Sleep + Immune Support with melatonin; Novastell launches Preminity for PMS; Prunelax in gummy; and lion’s mane mushroom in Clear Focus.

US Q2 Consumer Health Earnings Preview: Horizon Brightens Beyond Current Questions, Challenges?

Consumer health product firms’ vistas include challenges of supply chain disruptions lingering from pandemic’s impact as well as potential for marketplace restrictions as additional varieties of the novel coronavirus spread. Clouds also include shifts in consumer spending, increases in costs caused by inflation and foreign exchange headwinds as the value of the US dollar strengthens against other currencies.

Distribution Drives C&D’s TheraBreath Growth Plan

In addition to advertising brand to consumers and expanding distribution,, C&D will promote TheraBreath dental hygienists along with to Waterpik power brushes and water-flossers.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel